Bridgeway Capital Management’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Bridgeway Capital Management’s Portfolio AXLA Stock Details AXLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,016	Closed	-$43.7K	–	1456
2023 Q2	$43.7K	Hold	8,016	–	–	﹤0.01%	1341
2023 Q1	$96.2K	Hold	8,016	–	–	﹤0.01%	1247
2022 Q4	$65.6K	Sell	8,016 -2,000	-20%	-$51.8K	﹤0.01%	1275
2022 Q3	$428K	Hold	10,016	–	–	0.01%	928
2022 Q2	$508K	Hold	10,016	–	–	0.01%	872
2022 Q1	$644K	Buy	10,016 +3,200	+47%	+$160K	0.01%	880
2021 Q4	$356K	Hold	6,816	–	–	0.01%	1059
2021 Q3	$508K	Buy	6,816 +1,297	+24%	+$111K	0.01%	1027
2021 Q2	$553K	Sell	5,519 -980	-15%	-$97.1K	0.01%	1041
2021 Q1	$773K	Buy	6,499 +4,000	+160%	+$564K	0.01%	959
2020 Q4	$324K	Buy	2,499 +1,985	+386%	+$255K	0.01%	1098
2020 Q3	$59K	Hold	514	–	–	﹤0.01%	1292
2020 Q2	$71K	Buy	+514	New	+$62.9K	﹤0.01%	1265

Other funds holding AXLA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bridgeway Capital Management's AXLA Position: Q3 2023 in Review

Bridgeway Capital Management sold out of Axcella Health Inc. Common Stock (AXLA) in Q3 2023, closing a stake of 8,016 shares — an estimated $43.7K sold.

Bridgeway Capital Management first reported a position in AXLA in Q2 2020 and held it in 13 quarters. The position peaked at $773K in Q1 2021. 15 funds tracked by Wall St. Rank hold AXLA as of Q3 2023.

Bridgeway Capital Management reported no remaining Axcella Health Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Bridgeway Capital Management sold 8,016 Axcella Health Inc. Common Stock shares in Q3 2023, an estimated $43.7K.
Bridgeway Capital Management first reported a position in Axcella Health Inc. Common Stock in Q2 2020 and held it in 13 quarters.
Bridgeway Capital Management's Axcella Health Inc. Common Stock position peaked at $773K in Q1 2021.
15 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q3 2023.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.